Who We Are
SpectrumX is a UK-based pharmaceutical manufacturer specialising in the production of high-quality liquid products for healthcare, wellness, and infection prevention.
About Us
Operating an MHRA-licensed site for unlicensed medicines. SpectrumX combines scientific precision with scalable, high-quality production.
Our mission is to deliver trusted, compliant, and innovative solutions that meet the highest international manufacturing standards while supporting sustainable and responsible production practices.
Our Commitment
- Quality and Compliance: Every SpectrumX product is manufactured under strict regulatory oversight, ensuring consistency, safety, and reliability.
- Export Capability: We meet international requirements and supply our products to regulated markets worldwide under GDP conditions.
- Transparency and Accountability: We maintain open, traceable processes and uphold regulatory trust in all our operations.
- Sustainability: We are committed to reducing our environmental impact and supporting long-term responsible manufacturing.
- Pharmaceutical-Grade Assurance: Each product is manufactured with full traceability, under robust systems for quality and compliance.
Board of Directors
CEO
Damien Hancox
Damien Hancox is an accomplished pharma-industry operator and commercial leader known for building high-performing teams and turning complex healthcare problems into scalable, metric-based outcomes.
As CEO of SpectrumX, he played a pivotal role in accelerating the company’s growth including identifying the commercial opportunites in the “specials” market. SpectrumX are now one of the largest output specials manufactures in the UK.
With deep experience across the pharmaceutical ecosystem, Damien has worked closely with stakeholders spanning manufacturers, distributors and healthcare providers, with a focus on improving access, affordability, and patient outcomes. He brings a pragmatic, data-driven approach to leadership, combining market insight with disciplined execution to deliver results in highly regulated environments.
Damien is valued for his ability to align cross-functional teams, convert multifaceted challenges into scalable business solutions, and build trusted partnerships—consistently driving momentum from early-stage opportunity through to sustained impact.
CFO
Barry Saint
A Cambridge University Engineering graduate, Barry has over 20 years’ experience as a FTSE-250 global finance and strategy leader. Additionally he is a seasoned investment banker. Extensively experienced at raising capital for growth companies, including at IPO and from venture/private equity sources, he has also worked with company boards and backers to source and secure value-accretive collaborations and M&A, often internationally.
He has served as CFO of an early stage biotechnology company and as Group Treasurer of a $1 billion revenue pharmaceutical business, Indivior. He has built and led high performing finance and multi-disciplinary teams servicing operations in over 40 countries. In the US, he acquired substantial healthcare industry experience. He oversaw the upgrading of financial reporting processes, controls and led collaborations enabling significant growth.
Barry commenced his advisory career as a strategy consultant with KPMG, before moving into investment banking with Dresdner Kleinwort.
OPERATIONS DIRECTOR
Ben Hibbert
Ben has worked in science and pharmaceuticals for over 20 years. Initially as a chartered surveyor and project manager delivering facilities supporting these sectors before expanding into operations.
Having been with SpectrumX from the beginning he helped to shape and deliver the strategic objectives for the business and now heads up operational functions including supporting key projects from inception to successful completion.
Outside of work, Ben enjoys spending time with his family and running.
IN HOUSE COUNCIL
David Jones
David’s legal journey began when he was called to the Bar in 2006. After honing his skills as an in-house lawyer in London, he cross-qualified as a Solicitor in 2009. Since then, his tenacity, strategic problem-solving and sharp business acumen have earned him consistent recognition in the Legal 500.
While David is primarily known as a formidable litigator, his clients – drawn from various sectors – rely on him for comprehensive advice on matters critical to their business interests and wealth protection. David’s dedication to his clients, coupled with his deep understanding of the legal landscape, makes him an indispensable asset to those he represents.
NON-EXECUTIVE DIRECTOR, AUDIT COMMITTEE CHAIR
Debra Leeves
Debra has worked in technology companies and the pharmaceutical industry for the past 25 years, leading companies in the US, Asia-Pac, and Europe. During her career she has held various senior and C-level positions both in start-ups and large multinationals, including Pfizer, GSK, and GE. Her experience spans both business and clinical roles including sales, marketing, finance, quality, and medical affairs.
She is currently CEO for Vertual Ltd, a leading global supplier of virtual reality (VR) training systems, and prior to that was CEO for Physeon GmbH, and Managing Director for Avita Medical Ltd.
She has held public and listed company board roles and is currently Chair of Atelerix, Chair of the Institute of Directors (East Yorkshire), Non-Executive Director of Cambridge Cognition, and is the commercial champion and mentor for several university spinouts. She has a degree in Pharmacy, an MBA from Warwick Business school and is a part qualified Management Accountant (CIMA).
Key People
QUALITY DIRECTOR
Omair Sattar
With over a decade of experience in pharmaceutical quality, Omair Sattar has built a strong track record across sterile, non-sterile, and GMP-regulated environments. As Quality Director at SpectrumX, he leads strategic quality initiatives, regulatory compliance, and operational excellence across the organisation.
He has successfully led Quality Assurance, Quality Control, and R&D teams in both clinical and commercial settings, with expertise spanning regulatory inspections, QMS implementation, batch release, deviation management, and supplier qualification.
His background includes clinical research, pharmaceutical manufacturing, and the importation of cannabis-based medicinal products. As a Responsible Person (RP) on multiple MHRA licences—including MIA(IMP), MS, and WDA(H)—he ensures that all products and processes meet the highest standards of patient safety and regulatory compliance. Committed to continuous improvement, he consistently upholds robust, inspection-ready quality systems that foster innovation and trust.
REGULATORY AFFAIRS MANAGER | QUALITY ASSURANCE MANAGER
Eman Alqadoori
Eman Alqadoori is a senior Quality and Regulatory leader at SpectrumX, supporting the company’s mission to deliver high-quality pharmaceutical solutions with speed, integrity, and patient focus. She holds a Master’s degree in Pharmaceutical Sciences and an MBA, combining strong scientific judgement with commercial and strategic insight. With nearly 20 years of experience across regulated healthcare environments, Eman works closely with internal teams and external partners to enable efficient product development, ensure compliance across the supply chain, and support sustainable business growth.
MANUFACTURING MANAGER
Michael Ruddick
Michael Ruddick is a Manufacturing Manager with over 30 years of experience in pharmaceutical manufacturing. Having progressed from operator to senior leadership roles, he has a deep understanding of GMP operations. His background includes biologics, aseptic and oral solid dose manufacturing, as well as work with controlled drugs and high potency products.
GENERAL MANAGER
Richard Jones
Richard Jones has had a career in logistics and operational management for both the public and the private sector. He has held a series of roles which included responsibility for developing, implementing and the ongoing management of quality management systems to achieve and maintain ISO 9001 accreditation in a range of settings. With a proactive, strong customer focus and a can-do approach he is an experienced general manager possessing particular expertise in project management, driving efficiencies through cost control and reduction and a strong focus on engendering a culture of continuous improvement within the businesses that he has managed.
MARKETING DIRECTOR
Jennifer Von Strohe
Jennifer Von Strohe is a senior marketing and commercial leader with over 25 years of global experience building brands, driving growth, and translating complex, regulated products into clear, scalable market strategies across pharmaceutical manufacturing, biotech, fintech, FMCG, and digital industries.
As a founding member of SpectrumX, Jennifer has spent the past six years helping to build the company from inception into one of the UK’s leading output specials manufacturers. Serving as Marketing Director since launch, she has led the full breadth of marketing and commercial activity—spanning product line launches, regulatory and compliance communications, market positioning, go-to-market strategy, stakeholder engagement, and brand development within a highly regulated pharmaceutical environment.
Working in close partnership with the executive team, including CEO Damien Hancox, Jennifer has played a pivotal role in shaping SpectrumX’s commercial narrative, supporting expansion into the “specials” market, and aligning marketing strategy with operational, regulatory, and growth objectives. Her remit has extended well beyond traditional marketing, encompassing cross-functional collaboration with manufacturing, quality, compliance, and leadership teams to ensure clarity, credibility, and consistency across all external and internal communications.
Prior to SpectrumX, Jennifer held senior leadership roles across high-growth startups and established organisations, where she led global brand transformations, digital innovation initiatives, integrated marketing programmes, and product-driven growth strategies. She is recognised for her ability to simplify complexity, connect strategy to execution, and build marketing frameworks that scale with the business.
Jennifer brings a pragmatic, data-informed approach balanced with strong creative and commercial insight, enabling organisations to grow sustainably while navigating fast-moving and highly regulated markets. She holds a double major in Marketing and Management with a minor in Psychology and is based in Greater London, UK.
Investor Relations
SpectrumX is dedicated to transparent communication and long-term value creation for our investors. Our focus on compliance, innovation, and operational excellence positions us as a trusted partner in the pharmaceutical manufacturing sector. For investor inquiries or partnership opportunities, please contact us.
Let’s Talk
To discuss your manufacturing requirements or learn more about our capabilities, fill in the form below.
Manufacturing excellence, built on quality and compliance.
